Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.05 trillion and total revenue of $109.95 billion.
Market Cap
1.05T
Revenue
109.95B
Profits
-42.27B
PE Ratio
n/a
Profit Margin
-38.45%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.63B | -0.61% | 1,152,214 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.87B | 0.50% | 535,937 | 14.34B |
| 3 | ARGX | argenx SE | 42.20B | 2.70% | 391,070 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.67B | -1.77% | 1,378,964 | 3.71B |
| 5 | INSM | Insmed Incorporated | 31.04B | 5.87% | 4,079,400 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 30.45B | -0.20% | 208,474 | 5.34B |
| 7 | BNTX | BioNTech SE | 22.22B | -0.96% | 1,191,939 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.25B | -0.19% | 5,977,244 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.99B | 0.83% | 4,912,260 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.54B | 0.55% | 3,795,330 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.15B | 0.89% | 1,366,525 | - |
| 12 | INCY | Incyte Corporation | 18.00B | -0.36% | 1,415,693 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.75B | 2.31% | 1,319,772 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.49B | 1.55% | 1,434,215 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.38B | -1.72% | 385,976 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.10B | 0.58% | 2,157,972 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.69B | -0.28% | 2,198,127 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.22B | 0.94% | 745,379 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.75B | 0.34% | 2,614,121 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.54B | 1.20% | 1,868,298 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.27B | 1.49% | 222,397 | 958.40M |
| 22 | IBRX | ImmunityBio, Inc. | 9.66B | 10.98% | 26,747,949 | 113.29M |
| 23 | ABVX | ABIVAX Société Anonyme | 9.06B | -4.09% | 1,288,417 | 5.37M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.19B | -1.41% | 644,445 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 8.14B | 1.01% | 1,628,639 | 1.22B |
| 26 | PCVX | Vaxcyte, Inc. | 8.05B | 2.23% | 1,073,391 | - |
| 27 | AXSM | Axsome Therapeutics, Inc. | 8.02B | -0.05% | 409,886 | 638.50M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.94B | 0.60% | 2,001,298 | 1.09B |
| 29 | NUVL | Nuvalent, Inc. | 7.58B | 1.75% | 496,138 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.51B | -1.22% | 1,523,247 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.42B | -0.90% | 1,910,645 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.31B | -0.64% | 274,779 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.15% | 1,958,280 | 22.29M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.29B | -0.33% | 925,424 | 46.02M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.28B | -1.22% | 707,152 | 39.21M |
| 36 | BLTE | Belite Bio, Inc | 5.95B | -2.23% | 153,811 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.78B | -3.20% | 1,010,601 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.75B | 6.08% | 2,842,609 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 5.51B | 19.99% | 3,485,529 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.50B | 1.72% | 1,055,043 | 1.73B |
| 41 | CGON | CG Oncology, Inc. | 5.48B | -0.18% | 1,883,808 | 4.04M |
| 42 | CAI | Caris Life Sciences, Inc. | 5.44B | 4.62% | 3,729,767 | 812.03M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.40B | 1.04% | 1,347,101 | 521.31M |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 5.19B | -0.95% | 1,558,097 | 7.50M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.02B | -2.20% | 1,634,907 | - |
| 46 | IMVT | Immunovant, Inc. | 4.96B | 6.09% | 1,684,964 | - |
| 47 | CELC | Celcuity Inc. | 4.94B | 0.67% | 517,444 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 4.86B | 1.26% | 1,965,154 | 616.29M |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.07% | 2,652,292 | 634.21M |
| 50 | CRSP | CRISPR Therapeutics AG | 4.50B | 1.38% | 1,443,348 | 3.51M |
| 51 | TERN | Terns Pharmaceuticals, Inc. | 4.47B | 2.42% | 3,606,343 | - |
| 52 | ERAS | Erasca, Inc. | 4.45B | -1.92% | 5,192,980 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.00B | -2.17% | 263,562 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.76B | 0.68% | 2,281,917 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.63B | -2.42% | 2,203,301 | 7.70M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 3.58B | 1.21% | 1,414,578 | 1.07B |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.58B | -2.92% | 1,338,954 | 761.41M |
| 58 | DNTH | Dianthus Therapeutics, Inc. | 3.53B | 2.01% | 1,146,682 | 2.04M |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.49B | -4.14% | 1,536,730 | 15.00M |
| 60 | GPCR | Structure Therapeutics Inc. | 3.48B | 0.97% | 1,423,498 | - |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.45B | 3.70% | 789,910 | 22.50M |
| 62 | SYRE | Spyre Therapeutics, Inc. | 3.36B | 3.66% | 779,447 | - |
| 63 | DNLI | Denali Therapeutics Inc. | 3.34B | 4.56% | 1,663,703 | - |
| 64 | ADMA | ADMA Biologics, Inc. | 3.24B | -5.10% | 5,386,889 | 510.17M |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.20B | 2.55% | 713,355 | - |
| 66 | LEGN | Legend Biotech Corporation | 3.19B | -1.03% | 1,494,976 | 1.03B |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.09B | 4.34% | 244,007 | 803.79M |
| 68 | ALMS | Alumis Inc. | 2.97B | -6.78% | 2,100,304 | 24.05M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.95B | 1.77% | 2,151,136 | - |
| 70 | VERA | Vera Therapeutics, Inc. | 2.91B | 0.49% | 1,483,225 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.85B | 2.33% | 1,541,729 | 588.99M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.82B | 2.37% | 1,655,187 | 70.85M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.78B | -3.39% | 2,005,311 | 218.71M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.76B | 0.36% | 1,034,264 | 376.07M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.73B | -0.59% | 808,346 | 451.36M |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.71B | -2.37% | 3,551,042 | 62.38M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.68B | -1.06% | 923,850 | 247.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.56B | 2.19% | 1,295,345 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.56B | 3.39% | 1,734,164 | 490.73M |
| 80 | MAZE | Maze Therapeutics, Inc. | 2.36B | 2.02% | 523,736 | 2.50M |
| 81 | IMNM | Immunome, Inc. | 2.35B | 3.70% | 1,220,647 | 6.94M |
| 82 | MANE | Veradermics, Incorporated | 2.31B | 5.15% | 291,846 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.26B | 1.62% | 344,150 | - |
| 84 | APLS | Apellis Pharmaceuticals, Inc. | 2.25B | 2.09% | 2,408,495 | 1.00B |
| 85 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.37% | 1,710,459 | 158.18M |
| 86 | WVE | Wave Life Sciences Ltd. | 2.19B | -1.19% | 3,807,374 | 42.73M |
| 87 | NKTR | Nektar Therapeutics | 2.13B | 2.94% | 699,973 | 55.23M |
| 88 | SNDX | Syndax Pharmaceuticals, Inc. | 2.12B | -0.58% | 918,241 | 172.35M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.12B | 2.91% | 1,496,617 | 1.55M |
| 90 | ADPT | Adaptive Biotechnologies Corporation | 2.10B | 0.59% | 1,274,970 | 276.98M |
| 91 | GLPG | Galapagos NV | 2.10B | -0.34% | 99,544 | 1.31B |
| 92 | AAPG | Ascentage Pharma Group International | 2.07B | 16.80% | 14,172 | 54.52M |
| 93 | ORKA | Oruka Therapeutics, Inc. | 2.06B | 6.81% | 562,087 | - |
| 94 | STOK | Stoke Therapeutics, Inc. | 1.98B | -0.33% | 441,275 | 184.42M |
| 95 | TYRA | Tyra Biosciences, Inc. | 1.97B | -1.70% | 969,096 | - |
| 96 | RARE | Ultragenyx Pharmaceutical Inc. | 1.96B | 2.01% | 2,065,810 | 673.00M |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -1.74% | 1,323,718 | - |
| 98 | ZLAB | Zai Lab Limited | 1.95B | -2.65% | 1,590,470 | 460.16M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.94B | 3.85% | 2,648,638 | 283.06M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | 6.11% | 2,942,742 | 2.20B |
| 101 | ELVN | Enliven Therapeutics, Inc. | 1.84B | 6.13% | 887,687 | - |
| 102 | MESO | Mesoblast Limited | 1.81B | -2.37% | 1,235,964 | 65.38M |
| 103 | DFTX | Definium Therapeutics, Inc. | 1.80B | -1.63% | 1,026,902 | - |
| 104 | ANAB | AnaptysBio, Inc. | 1.80B | 0.56% | 413,902 | 234.60M |
| 105 | ZYME | Zymeworks Inc. | 1.77B | 3.00% | 533,125 | 105.97M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 1.76B | -0.98% | 3,844,129 | 51.95M |
| 107 | RLAY | Relay Therapeutics, Inc. | 1.76B | -0.91% | 2,040,516 | 15.36M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.73B | 3.44% | 1,323,894 | 11.13M |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -0.62% | 11,203,331 | 74.68M |
| 110 | VCEL | Vericel Corporation | 1.65B | 3.31% | 711,077 | 276.26M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.90% | 811,883 | 54.03M |
| 112 | SION | Sionna Therapeutics, Inc. | 1.64B | 0.11% | 346,680 | - |
| 113 | SLNO | Soleno Therapeutics, Inc. | 1.64B | -4.52% | 969,277 | 190.41M |
| 114 | INVA | Innoviva, Inc. | 1.62B | 0.97% | 928,286 | 411.33M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.43% | 718,747 | 868.45M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.60B | 2.04% | 305,676 | 31.89M |
| 117 | NVAX | Novavax, Inc. | 1.58B | 1.04% | 5,300,961 | 1.12B |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.55B | 2.10% | 3,107,048 | 67.67M |
| 119 | IMCR | Immunocore Holdings plc | 1.54B | 1.47% | 270,814 | 400.02M |
| 120 | NUVB | Nuvation Bio Inc. | 1.51B | 3.08% | 4,444,689 | 62.90M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.51B | 1.80% | 860,240 | 83.98M |
| 122 | IOVA | Iovance Biotherapeutics, Inc. | 1.50B | -1.63% | 9,005,782 | 263.50M |
| 123 | NBTX | Nanobiotix S.A. | 1.48B | 5.20% | 90,539 | 11.93M |
| 124 | OCS | Oculis Holding AG | 1.46B | -1.05% | 249,755 | 1.51M |
| 125 | PHVS | Pharvaris N.V. | 1.41B | -1.15% | 220,463 | - |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.39B | 27.07% | 337,882 | - |
| 127 | PVLA | Palvella Therapeutics, Inc. | 1.39B | 4.04% | 249,200 | - |
| 128 | TRVI | Trevi Therapeutics, Inc. | 1.38B | 1.41% | 2,050,741 | - |
| 129 | MBX | MBX Biosciences, Inc. | 1.34B | -1.88% | 548,870 | - |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.33B | 3.06% | 310,195 | - |
| 131 | BHVN | Biohaven Ltd. | 1.31B | -2.13% | 1,402,699 | - |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | 3.18% | 1,737,973 | 9.77M |
| 133 | ARDX | Ardelyx, Inc. | 1.30B | - | 3,926,854 | 407.32M |
| 134 | IMTX | Immatics N.V. | 1.28B | 0.85% | 438,287 | 56.67M |
| 135 | VIR | Vir Biotechnology, Inc. | 1.23B | -2.86% | 2,039,524 | 68.56M |
| 136 | ATAI | AtaiBeckley Inc. | 1.23B | -2.87% | 5,307,564 | 4.09M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | -0.78% | 1,414,187 | - |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.21B | 3.69% | 776,527 | - |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.20B | -3.84% | 899,408 | 123.67M |
| 140 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -7.49% | 1,792,994 | 10.00M |
| 141 | KOD | Kodiak Sciences Inc. | 1.18B | -0.04% | 471,663 | - |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | 3.15% | 1,168,840 | - |
| 143 | PGEN | Precigen, Inc. | 1.15B | -1.22% | 3,155,878 | 6.31M |
| 144 | TVGN | Tevogen Bio Holdings Inc. | 1.12B | 6.32% | 40,383 | - |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -0.27% | 1,496,358 | - |
| 146 | PHAR | Pharming Group N.V. | 1.10B | 4.23% | 43,355 | 376.13M |
| 147 | EYPT | EyePoint, Inc. | 1.07B | -3.02% | 851,085 | 31.37M |
| 148 | SEPN | Septerna, Inc. | 1.07B | -1.65% | 288,165 | 45.95M |
| 149 | SVRA | Savara Inc. | 1.04B | 2.42% | 1,979,689 | - |
| 150 | ABCL | AbCellera Biologics Inc. | 1.02B | -0.88% | 2,358,659 | 75.13M |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.01B | -0.11% | 338,014 | - |
| 152 | QURE | uniQure N.V. | 995.47M | -1.06% | 2,364,622 | 16.10M |
| 153 | GERN | Geron Corporation | 986.44M | 5.48% | 19,754,109 | 183.88M |
| 154 | SLS | SELLAS Life Sciences Group, Inc. | 984.11M | 15.13% | 9,941,296 | - |
| 155 | AVBP | ArriVent BioPharma, Inc. | 980.39M | 0.73% | 494,497 | - |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 967.34M | 3.12% | 2,181,993 | 291.85M |
| 157 | AKTS | Aktis Oncology, Inc. | 954.86M | 2.71% | 583,656 | 5.56M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 944.05M | 6.09% | 202,102 | 1.30M |
| 159 | FTRE | Fortrea Holdings Inc. | 911.63M | 2.31% | 1,018,591 | 2.72B |
| 160 | CMPX | Compass Therapeutics, Inc. | 907.64M | -2.14% | 1,634,151 | 850.00K |
| 161 | XNCR | Xencor, Inc. | 883.73M | -0.66% | 1,516,697 | 125.58M |
| 162 | SGP | SpyGlass Pharma, Inc. | 877.91M | 1.35% | 160,735 | - |
| 163 | ABUS | Arbutus Biopharma Corporation | 864.01M | 4.25% | 7,626,047 | 14.08M |
| 164 | IVA | Inventiva S.A. | 846.04M | 5.19% | 251,003 | 19.93M |
| 165 | JANX | Janux Therapeutics, Inc. | 845.56M | -1.14% | 691,581 | 10.00M |
| 166 | EVMN | Evommune, Inc. | 844.63M | 0.51% | 192,051 | 13.00M |
| 167 | URGN | UroGen Pharma Ltd. | 842.20M | -1.82% | 414,871 | 109.79M |
| 168 | KALV | KalVista Pharmaceuticals, Inc. | 839.07M | -2.35% | 640,214 | 1.43M |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 832.90M | -5.71% | 794,580 | 175.11M |
| 170 | SANA | Sana Biotechnology, Inc. | 832.62M | 0.32% | 1,424,128 | - |
| 171 | GHRS | GH Research PLC | 819.41M | -5.44% | 293,911 | - |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 777.16M | 0.78% | 1,221,710 | - |
| 173 | ANL | Adlai Nortye Ltd. | 768.26M | -6.22% | 169,337 | -1.35M |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 761.61M | -6.12% | 1,767,525 | 84.28M |
| 175 | TBPH | Theravance Biopharma, Inc. | 759.52M | 2.93% | 888,714 | 107.46M |
| 176 | CTMX | CytomX Therapeutics, Inc. | 759.03M | 0.22% | 4,494,867 | 76.20M |
| 177 | OMER | Omeros Corporation | 755.80M | -3.09% | 1,185,912 | - |
| 178 | MNKD | MannKind Corporation | 751.77M | -1.21% | 6,293,253 | 348.97M |
| 179 | MPLT | MapLight Therapeutics, Inc. | 745.40M | -2.73% | 137,209 | - |
| 180 | KURA | Kura Oncology, Inc. | 734.90M | 0.73% | 1,423,875 | 67.48M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 721.96M | 1.19% | 176,759 | - |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 705.09M | 1.50% | 101,417 | - |
| 183 | SLDB | Solid Biosciences Inc. | 702.51M | 1.56% | 941,084 | - |
| 184 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.84M | 5.13% | 1,853,360 | 49.80M |
| 185 | OCGN | Ocugen, Inc. | 688.58M | 2.94% | 13,625,361 | 4.41M |
| 186 | JBIO | Jade Biosciences, Inc. | 685.00M | -0.79% | 378,845 | - |
| 187 | GYRE | Gyre Therapeutics, Inc. | 682.62M | 4.76% | 152,226 | 116.59M |
| 188 | ARVN | Arvinas, Inc. | 660.08M | -5.67% | 912,791 | 262.60M |
| 189 | PRME | Prime Medicine, Inc. | 646.38M | 1.70% | 2,073,559 | 4.63M |
| 190 | ANNX | Annexon, Inc. | 642.43M | 5.09% | 2,008,028 | - |
| 191 | ANRO | Alto Neuroscience, Inc. | 639.55M | -6.75% | 496,852 | - |
| 192 | DRTS | Alpha Tau Medical Ltd. | 633.67M | 1.84% | 218,956 | - |
| 193 | EIKN | Eikon Therapeutics, Inc. | 632.16M | -0.93% | 551,194 | - |
| 194 | MDXG | MiMedx Group, Inc. | 629.92M | 2.91% | 788,400 | 418.63M |
| 195 | DSGN | Design Therapeutics, Inc. | 627.21M | -1.36% | 277,726 | - |
| 196 | MGTX | MeiraGTx Holdings plc | 615.76M | 6.25% | 337,114 | 27.42M |
| 197 | RLMD | Relmada Therapeutics, Inc. | 614.66M | -3.46% | 1,748,073 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 598.83M | 0.59% | 129,379 | - |
| 199 | AGMB | AgomAb Therapeutics NV | 597.03M | 0.49% | 107,538 | - |
| 200 | ALLO | Allogene Therapeutics, Inc. | 594.82M | 17.87% | 11,688,885 | 22.00K |
| 201 | REPL | Replimune Group, Inc. | 576.36M | - | 1,614,283 | - |
| 202 | VALN | Valneva SE | 562.73M | -37.11% | 771,312 | 205.07M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 553.06M | 2.06% | 871,512 | 106.47M |
| 204 | TECX | Tectonic Therapeutic, Inc. | 552.78M | -1.47% | 195,904 | - |
| 205 | DBVT | DBV Technologies S.A. | 552.65M | 5.76% | 201,394 | 5.50M |
| 206 | ZURA | Zura Bio Limited | 528.49M | 1.27% | 511,150 | - |
| 207 | ADCT | ADC Therapeutics SA | 514.53M | 4.92% | 662,768 | 81.36M |
| 208 | CRMD | CorMedix Inc. | 507.50M | 2.72% | 1,428,605 | 311.71M |
| 209 | ENGN | enGene Holdings Inc. | 489.69M | 1.39% | 143,255 | - |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 489.54M | 2.08% | 243,664 | 294.28M |
| 211 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 4.23% | 1,925,434 | - |
| 212 | PRTA | Prothena Corporation plc | 474.81M | 0.80% | 487,557 | 9.68M |
| 213 | VSTM | Verastem, Inc. | 473.43M | -2.53% | 1,825,862 | 30.91M |
| 214 | FDMT | 4D Molecular Therapeutics, Inc. | 471.21M | 7.20% | 667,641 | 85.21M |
| 215 | RCKT | Rocket Pharmaceuticals, Inc. | 471.19M | 4.83% | 3,195,529 | - |
| 216 | CTNM | Contineum Therapeutics, Inc. | 463.71M | 1.72% | 828,207 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 458.88M | 1.77% | 877,098 | 80.00M |
| 218 | NAUT | Nautilus Biotechnology, Inc. | 457.22M | 19.47% | 1,099,211 | - |
| 219 | UPB | Upstream Bio, Inc. | 456.63M | -2.54% | 743,392 | 2.80M |
| 220 | YDES | YD Bio Limited | 456.38M | 18.86% | 23,377 | 510.36K |
| 221 | LYEL | Lyell Immunopharma, Inc. | 455.65M | 2.25% | 109,186 | 36.00K |
| 222 | ASMB | Assembly Biosciences, Inc. | 453.36M | 0.42% | 98,567 | 72.30M |
| 223 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.24M | 3.24% | 306,360 | - |
| 224 | MRVI | Maravai LifeSciences Holdings, Inc. | 449.40M | 3.02% | 3,484,911 | 185.74M |
| 225 | ALT | Altimmune, Inc. | 447.44M | 2.99% | 3,449,313 | 41.00K |
| 226 | AVIR | Atea Pharmaceuticals, Inc. | 443.77M | -1.59% | 491,482 | - |
| 227 | ABSI | Absci Corporation | 440.59M | -1.01% | 3,813,280 | 2.82M |
| 228 | TRDA | Entrada Therapeutics, Inc. | 439.89M | 1.59% | 225,520 | 25.42M |
| 229 | STTK | Shattuck Labs, Inc. | 437.97M | -1.61% | 1,074,033 | 1.00M |
| 230 | ACRS | Aclaris Therapeutics, Inc. | 431.73M | -2.98% | 2,036,286 | 7.83M |
| 231 | RGNX | REGENXBIO Inc. | 430.45M | 2.96% | 791,864 | 170.44M |
| 232 | IPSC | Century Therapeutics, Inc. | 425.94M | -2.07% | 3,645,768 | 109.16M |
| 233 | IVVD | Invivyd, Inc. | 421.07M | 7.97% | 2,451,838 | 53.43M |
| 234 | AURA | Aura Biosciences, Inc. | 414.68M | -0.31% | 228,527 | - |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 413.76M | -1.69% | 2,785,168 | 216.11M |
| 236 | NMRA | Neumora Therapeutics, Inc. | 412.71M | -1.59% | 518,582 | - |
| 237 | DNA | Ginkgo Bioworks Holdings, Inc. | 411.88M | 4.17% | 1,185,687 | 170.16M |
| 238 | AVXL | Anavex Life Sciences Corp. | 411.46M | 9.36% | 2,108,100 | - |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 404.35M | -1.95% | 737,192 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 384.42M | 1.91% | 120,755 | - |
| 241 | PRTC | PureTech Health plc | 381.04M | -0.19% | 2,826 | 6.39M |
| 242 | DMAC | DiaMedica Therapeutics Inc. | 379.64M | 7.84% | 314,741 | - |
| 243 | NAGE | Niagen Bioscience, Inc. | 377.18M | 1.07% | 997,358 | 129.42M |
| 244 | MNPR | Monopar Therapeutics Inc. | 375.96M | 1.90% | 127,884 | - |
| 245 | AUTL | Autolus Therapeutics plc | 372.60M | 2.19% | 1,343,187 | 51.13M |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | -4.91% | 361,900 | 35.11M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 367.09M | 1.12% | 114,136 | 66.98M |
| 248 | LCTX | Lineage Cell Therapeutics, Inc. | 366.16M | 1.38% | 1,695,759 | 14.56M |
| 249 | CADL | Candel Therapeutics, Inc. | 365.50M | 0.40% | 778,001 | - |
| 250 | XOMA | XOMA Royalty Corporation | 354.43M | 3.69% | 112,933 | 52.15M |
| 251 | STRO | Sutro Biopharma, Inc. | 353.38M | 3.14% | 301,221 | 102.48M |
| 252 | GLSI | Greenwich LifeSciences, Inc. | 349.55M | 4.69% | 113,831 | - |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 345.55M | -0.63% | 588,706 | - |
| 254 | LENZ | LENZ Therapeutics, Inc. | 344.19M | 4.96% | 1,486,006 | 17.50M |
| 255 | OVID | Ovid Therapeutics Inc. | 336.28M | -2.67% | 3,982,859 | 6.61M |
| 256 | IMRX | Immuneering Corporation | 331.02M | 1.99% | 709,898 | - |
| 257 | PEPG | PepGen Inc. | 330.37M | 1.70% | 656,996 | - |
| 258 | IRD | Opus Genetics, Inc. | 326.57M | 4.56% | 625,610 | 14.20M |
| 259 | FBRX | Forte Biosciences, Inc. | 320.81M | 8.98% | 298,282 | - |
| 260 | PBYI | Puma Biotechnology, Inc. | 317.98M | 2.12% | 255,123 | 228.37M |
| 261 | PALI | Palisade Bio, Inc. | 316.84M | 1.06% | 1,835,146 | - |
| 262 | CABA | Cabaletta Bio, Inc. | 313.93M | -4.08% | 3,630,643 | - |
| 263 | CLYM | Climb Bio, Inc. | 312.40M | 7.04% | 512,640 | - |
| 264 | AVTX | Avalo Therapeutics, Inc. | 307.64M | 0.60% | 2,592,216 | 59.00K |
| 265 | CBIO | Crescent Biopharma, Inc. | 304.23M | 1.28% | 198,722 | 10.84M |
| 266 | NBP | NovaBridge Biosciences | 303.22M | 2.73% | 302,409 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 302.53M | -0.23% | 831,238 | 72.59M |
| 268 | NGNE | Neurogene Inc. | 299.88M | 1.63% | 114,852 | 925.00K |
| 269 | FHTX | Foghorn Therapeutics Inc. | 298.78M | 1.80% | 166,355 | 30.91M |
| 270 | IMMX | Immix Biopharma, Inc. | 295.82M | -3.29% | 848,202 | - |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 293.91M | -3.58% | 30,474 | 5.05M |
| 272 | ACIU | AC Immune SA | 293.11M | 1.05% | 122,020 | 4.51M |
| 273 | SRZN | Surrozen, Inc. | 289.92M | 0.36% | 72,121 | 3.48M |
| 274 | ALXO | ALX Oncology Holdings Inc. | 289.54M | 0.92% | 913,537 | - |
| 275 | NERV | Minerva Neurosciences, Inc. | 283.45M | -13.13% | 681,377 | - |
| 276 | TARA | Protara Therapeutics, Inc. | 279.08M | -0.96% | 858,994 | - |
| 277 | OBIO | Orchestra BioMed Holdings, Inc. | 278.56M | 2.59% | 295,645 | 33.48M |
| 278 | CNTX | Context Therapeutics Inc. | 277.48M | 4.86% | 489,127 | - |
| 279 | PROK | ProKidney Corp. | 275.37M | 0.52% | 805,610 | 893.00K |
| 280 | SLN | Silence Therapeutics plc | 272.78M | -6.40% | 431,741 | 559.00K |
| 281 | PLYX | Polaryx Therapeutics, Inc. | 261.33M | -0.36% | 521,444 | - |
| 282 | OABI | OmniAb, Inc. | 254.82M | 0.57% | 232,578 | 18.67M |
| 283 | CLLS | Cellectis S.A. | 252.56M | 2.40% | 32,727 | 79.59M |
| 284 | ABEO | Abeona Therapeutics Inc. | 252.16M | -0.67% | 1,623,249 | 5.82M |
| 285 | CCCC | C4 Therapeutics, Inc. | 249.80M | -5.19% | 2,696,313 | 35.95M |
| 286 | CHRS | Coherus Oncology, Inc. | 245.82M | 7.89% | 1,256,354 | 42.17M |
| 287 | TENX | Tenax Therapeutics, Inc. | 245.41M | -0.21% | 225,668 | - |
| 288 | CAMP | Camp4 Therapeutics Corporation | 243.50M | -6.20% | 118,541 | 3.50M |
| 289 | ELDN | Eledon Pharmaceuticals, Inc. | 235.14M | 7.64% | 2,067,345 | - |
| 290 | EDIT | Editas Medicine, Inc. | 234.89M | 2.56% | 1,237,225 | 40.52M |
| 291 | VYGR | Voyager Therapeutics, Inc. | 231.25M | 0.91% | 612,066 | 40.37M |
| 292 | RZLT | Rezolute, Inc. | 229.67M | -3.61% | 1,042,818 | - |
| 293 | ALEC | Alector, Inc. | 227.35M | 0.49% | 408,741 | 21.05M |
| 294 | HELP | Cybin Inc. | 227.16M | -1.73% | 686,171 | - |
| 295 | KROS | Keros Therapeutics, Inc. | 221.63M | 2.55% | 464,226 | 244.06M |
| 296 | NVCT | Nuvectis Pharma, Inc. | 218.82M | 0.36% | 66,538 | - |
| 297 | MDWD | MediWound Ltd. | 216.66M | -0.47% | 62,686 | 16.96M |
| 298 | ACHV | Achieve Life Sciences, Inc. | 215.60M | 1.25% | 568,647 | - |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 215.56M | 7.20% | 563,060 | 13.11M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 209.47M | 1.78% | 207,396 | 38.79M |
| 301 | ELTX | Elicio Therapeutics, Inc. | 200.70M | 0.55% | 92,721 | - |
| 302 | SABS | SAB Biotherapeutics, Inc. | 200.24M | 4.80% | 525,623 | 114.70K |
| 303 | PRLD | Prelude Therapeutics Incorporated | 199.09M | 5.69% | 164,083 | 12.14M |
| 304 | CGEN | Compugen Ltd. | 197.62M | - | 230,145 | 72.76M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 195.27M | 3.62% | 584,957 | 82.03M |
| 306 | CBUS | Cibus, Inc. | 191.67M | 11.69% | 578,996 | 3.64M |
| 307 | MGNX | MacroGenics, Inc. | 185.58M | 2.10% | 797,096 | 149.50M |
| 308 | ADAG | Adagene Inc. | 184.75M | 7.99% | 154,016 | 103.20K |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 184.44M | -9.28% | 16,128 | 19.39M |
| 310 | GALT | Galectin Therapeutics Inc. | 184.39M | 4.00% | 150,851 | - |
| 311 | ZNTL | Zentalis Pharmaceuticals, Inc. | 182.79M | -3.44% | 416,504 | 26.87M |
| 312 | CRBU | Caribou Biosciences, Inc. | 179.75M | -0.53% | 789,847 | 11.16M |
| 313 | NTHI | NeOnc Technologies Holdings, Inc. | 178.81M | 7.80% | 30,450 | 59.99K |
| 314 | RNAC | Cartesian Therapeutics, Inc. | 174.96M | 1.38% | 119,814 | 2.80M |
| 315 | WHWK | Whitehawk Therapeutics, Inc. | 172.27M | 1.67% | 111,971 | 7.15M |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 172.07M | 0.45% | 350,457 | - |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 171.30M | -0.47% | 958,082 | 52.74M |
| 318 | MIST | Milestone Pharmaceuticals Inc. | 168.94M | -7.35% | 4,234,309 | 1.55M |
| 319 | MOLN | Molecular Partners AG | 168.73M | -1.64% | 1,137 | 856.30K |
| 320 | CNTB | Connect Biopharma Holdings Limited | 164.92M | 6.88% | 222,934 | 762.00K |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 164.15M | 1.50% | 588,287 | - |
| 322 | PRQR | ProQR Therapeutics N.V. | 163.31M | 0.65% | 216,481 | 19.19M |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 163.07M | 0.04% | 3,463,463 | - |
| 324 | KRRO | Korro Bio, Inc. | 162.54M | 4.84% | 159,371 | 6.39M |
| 325 | EVAX | Evaxion A/S | 161.80M | -0.77% | 24,198 | 7.53M |
| 326 | DTIL | Precision BioSciences, Inc. | 161.22M | - | 222,770 | 34.26M |
| 327 | PMN | ProMIS Neurosciences, Inc. | 159.36M | 0.97% | 7,653 | - |
| 328 | HUMA | Humacyte, Inc. | 159.24M | 8.61% | 13,437,286 | 1.57M |
| 329 | SGMT | Sagimet Biosciences Inc. | 159.02M | 1.24% | 302,165 | - |
| 330 | NKTX | Nkarta, Inc. | 154.84M | 1.87% | 445,600 | - |
| 331 | IMUX | Immunic, Inc. | 152.64M | 6.36% | 1,823,615 | - |
| 332 | HRTX | Heron Therapeutics, Inc. | 150.75M | 2.70% | 1,084,908 | 154.90M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.52M | -1.98% | 164,779 | - |
| 334 | KLRS | Kalaris Therapeutics, Inc. | 149.03M | -1.07% | 41,026 | - |
| 335 | VTVT | vTv Therapeutics Inc. | 146.83M | 3.56% | 41,547 | 17.00K |
| 336 | CDXS | Codexis, Inc. | 146.30M | 0.63% | 1,950,550 | 70.39M |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 145.50M | 0.59% | 221,856 | - |
| 338 | MENS | Jyong Biotech Ltd. | 144.76M | 14.71% | 185,845 | - |
| 339 | AGEN | Agenus Inc. | 141.69M | -0.54% | 303,760 | 114.20M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 141.30M | 1.72% | 106,485 | 2.00M |
| 341 | ANTX | AN2 Therapeutics, Inc. | 137.65M | -4.25% | 344,942 | - |
| 342 | ALDX | Aldeyra Therapeutics, Inc. | 134.21M | 23.20% | 7,071,639 | - |
| 343 | FATE | Fate Therapeutics, Inc. | 133.70M | 4.55% | 1,511,782 | 6.65M |
| 344 | ARTV | Artiva Biotherapeutics, Inc. | 132.73M | 0.94% | 83,940 | 251.00K |
| 345 | SPRO | Spero Therapeutics, Inc. | 132.40M | -0.84% | 176,547 | 40.55M |
| 346 | VOR | Vor Biopharma Inc. | 132.11M | 5.40% | 1,125,144 | - |
| 347 | IKT | Inhibikase Therapeutics, Inc. | 130.81M | -3.33% | 1,091,712 | 1.00 |
| 348 | IPHA | Innate Pharma S.A. | 128.40M | 17.09% | 63,632 | 14.84M |
| 349 | ACOG | Alpha Cognition Inc. | 126.10M | 1.58% | 49,890 | 7.43M |
| 350 | BDTX | Black Diamond Therapeutics, Inc. | 123.17M | 1.90% | 397,698 | 70.00M |
| 351 | EQ | Equillium, Inc. | 123.00M | -5.16% | 433,934 | 4.39M |
| 352 | KPTI | Karyopharm Therapeutics Inc. | 122.17M | -12.71% | 967,061 | 146.07M |
| 353 | CRDF | Cardiff Oncology, Inc. | 121.69M | -1.11% | 433,929 | 593.00K |
| 354 | SGMO | Sangamo Therapeutics, Inc. | 112.73M | 0.99% | 5,885,640 | 32.88M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 111.24M | 1.90% | 978,390 | 65.34K |
| 356 | RANI | Rani Therapeutics Holdings, Inc. | 111.20M | 0.88% | 885,365 | 1.20M |
| 357 | GNLX | Genelux Corporation | 111.12M | 3.33% | 363,198 | 8.00K |
| 358 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 104.35M | 11.62% | 1,294,479 | - |
| 359 | ONCY | Oncolytics Biotech Inc. | 101.94M | -0.28% | 543,164 | - |
| 360 | HURA | TuHURA Biosciences, Inc. | 101.49M | 2.06% | 834,866 | - |
| 361 | TTRX | Turn Therapeutics Inc. | 100.70M | -0.58% | 3,601 | - |
| 362 | CGTX | Cognition Therapeutics, Inc. | 99.75M | 5.61% | 612,567 | - |
| 363 | COYA | Coya Therapeutics, Inc. | 98.99M | 0.24% | 90,099 | 7.95M |
| 364 | QTTB | Q32 Bio Inc. | 98.90M | 1.20% | 531,381 | 53.74M |
| 365 | SEER | Seer, Inc. | 96.76M | 2.08% | 147,128 | 16.58M |
| 366 | DWTX | Dogwood Therapeutics, Inc. | 92.86M | -7.33% | 39,565 | - |
| 367 | FBIO | Fortress Biotech, Inc. | 92.49M | -0.33% | 651,155 | 62.30M |
| 368 | MAIA | MAIA Biotechnology, Inc. | 90.40M | 2.05% | 381,015 | - |
| 369 | PYXS | Pyxis Oncology, Inc. | 89.22M | -3.40% | 328,871 | 13.86M |
| 370 | AARD | Aardvark Therapeutics, Inc. | 88.68M | -0.12% | 214,041 | - |
| 371 | GOSS | Gossamer Bio, Inc. | 87.59M | -11.65% | 28,704,225 | 48.47M |
| 372 | ANIX | Anixa Biosciences, Inc. | 87.51M | -1.51% | 115,982 | - |
| 373 | VANI | Vivani Medical, Inc. | 86.08M | 1.72% | 148,353 | - |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 83.32M | -11.01% | 141,147 | 35.58M |
| 375 | MCRB | Seres Therapeutics, Inc. | 83.11M | 2.00% | 78,197 | 789.00K |
| 376 | CSBR | Champions Oncology, Inc. | 82.77M | 1.71% | 3,324 | 57.95M |
| 377 | NRXS | NeurAxis, Inc. | 81.78M | -4.07% | 266,347 | 3.57M |
| 378 | ATYR | aTyr Pharma, Inc. | 81.13M | 2.36% | 896,809 | 190.00K |
| 379 | SPRB | Spruce Biosciences, Inc. | 80.72M | 0.74% | 29,489 | 697.00K |
| 380 | CING | Cingulate Inc. | 80.59M | -6.10% | 555,532 | - |
| 381 | PLRX | Pliant Therapeutics, Inc. | 79.87M | - | 312,273 | - |
| 382 | BMEA | Biomea Fusion, Inc. | 79.19M | -1.75% | 1,058,105 | - |
| 383 | KZIA | Kazia Therapeutics Limited | 77.58M | -4.81% | 34,350 | 1.20M |
| 384 | PMVP | PMV Pharmaceuticals, Inc. | 77.33M | -1.36% | 527,102 | - |
| 385 | IBIO | iBio, Inc. | 76.34M | 5.74% | 683,673 | 300.00K |
| 386 | PYPD | PolyPid Ltd. | 75.55M | -0.24% | 40,540 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 73.82M | 6.08% | 1,199 | 16.80M |
| 388 | XBIT | XBiotech Inc. | 72.87M | - | 51,212 | - |
| 389 | MNOV | MediciNova, Inc. | 71.37M | -7.05% | 57,000 | 409.66K |
| 390 | ANVS | Annovis Bio, Inc. | 70.89M | -3.85% | 345,852 | - |
| 391 | IFRX | InflaRx N.V. | 69.97M | 2.97% | 213,832 | 34.44K |
| 392 | IBO | Impact BioMedical Inc. | 69.74M | -17.08% | 1,163,979 | 32.00K |
| 393 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.83M | -2.12% | 24,803 | 1.36M |
| 394 | GRCE | Grace Therapeutics, Inc. | 68.55M | 0.23% | 200,544 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 68.22M | -3.08% | 811,607 | - |
| 396 | BYSI | BeyondSpring Inc. | 66.55M | 3.12% | 20,302 | 1.88M |
| 397 | EDSA | Edesa Biotech, Inc. | 64.95M | 5.85% | 1,059,352 | - |
| 398 | ACET | Adicet Bio, Inc. | 63.91M | -3.76% | 160,385 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 61.99M | -3.61% | 409,861 | - |
| 400 | EXOZ | eXoZymes, Inc. | 61.90M | 2.36% | 1,167 | -700.00 |
| 401 | GUTS | Fractyl Health, Inc. | 61.11M | 1.04% | 3,080,953 | 3.00K |
| 402 | IMA | ImageneBio, Inc. | 59.98M | -1.05% | 12,462 | 800.00K |
| 403 | ATHE | Alterity Therapeutics Limited | 59.81M | 0.30% | 1,566 | 4.43M |
| 404 | HYFT | MindWalk Holdings Corp. | 59.60M | 3.45% | 118,313 | 20.70M |
| 405 | TCRX | TScan Therapeutics, Inc. | 59.18M | - | 546,117 | 10.33M |
| 406 | NRXP | NRx Pharmaceuticals, Inc. | 58.53M | -4.32% | 781,398 | 242.00K |
| 407 | ICCC | ImmuCell Corporation | 57.98M | 5.60% | 5,020 | 27.64M |
| 408 | TIL | Instil Bio, Inc. | 57.10M | -1.52% | 14,705 | - |
| 409 | ACTU | Actuate Therapeutics, Inc. | 56.71M | 3.83% | 40,585 | - |
| 410 | IMMP | Immutep Limited | 56.54M | -2.41% | 802,800 | 5.28M |
| 411 | RADX | Radiopharm Theranostics Limited | 54.82M | -3.23% | 19,144 | 10.86M |
| 412 | MREO | Mereo BioPharma Group plc | 54.68M | 0.18% | 1,319,900 | 500.00K |
| 413 | OKUR | OnKure Therapeutics, Inc. | 54.42M | -5.01% | 196,060 | - |
| 414 | MGX | Metagenomi Therapeutics, Inc. | 53.80M | 0.70% | 183,281 | 25.21M |
| 415 | OSTX | OS Therapies Incorporated | 53.53M | -1.30% | 572,305 | - |
| 416 | LPCN | Lipocine Inc. | 53.36M | 2.24% | 115,244 | 1.98M |
| 417 | ENTX | Entera Bio Ltd. | 49.98M | -1.80% | 706,002 | 124.00K |
| 418 | ATOS | Atossa Therapeutics, Inc. | 48.31M | 5.25% | 65,602 | - |
| 419 | RLYB | Rallybio Corporation | 48.19M | 2.71% | 86,490 | 858.00K |
| 420 | DCOY | Decoy Therapeutics Inc. | 47.66M | - | 6,282 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 47.09M | - | 25,496 | - |
| 422 | NTRB | Nutriband Inc. | 46.21M | 4.07% | 13,549 | 2.28M |
| 423 | XLO | Xilio Therapeutics, Inc. | 45.45M | - | 39,988 | 43.77M |
| 424 | LSTA | Lisata Therapeutics, Inc. | 45.34M | 0.20% | 54,730 | 170.00K |
| 425 | GOVX | GeoVax Labs, Inc. | 45.09M | 2.04% | 104,849 | 3.35M |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | -3.03% | 104,556 | - |
| 427 | LITS | Lite Strategy, Inc. | 42.91M | 0.85% | 184,653 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 42.51M | 0.88% | 22,679 | 2.19M |
| 429 | PSTV | Plus Therapeutics, Inc. | 41.91M | -1.45% | 3,002,059 | 5.21M |
| 430 | INKT | MiNK Therapeutics, Inc. | 41.40M | -6.27% | 73,359 | - |
| 431 | SNSE | Sensei Biotherapeutics, Inc. | 41.36M | 3.87% | 89,645 | - |
| 432 | RNXT | RenovoRx, Inc. | 40.68M | 11.00% | 592,899 | 928.00K |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 39.97M | 4.77% | 109,039 | 1.14M |
| 434 | ATRA | Atara Biotherapeutics, Inc. | 39.62M | -1.32% | 67,886 | 120.77M |
| 435 | ESLA | Estrella Immunopharma, Inc. | 38.52M | -1.92% | 74,155 | - |
| 436 | APLM | Apollomics, Inc. | 38.22M | -3.73% | 3,658 | 6.93M |
| 437 | CRVO | CervoMed Inc. | 37.22M | - | 21,708 | 4.01M |
| 438 | NXTC | NextCure, Inc. | 37.06M | 4.20% | 11,750 | - |
| 439 | LONA | LeonaBio, Inc. | 36.95M | -5.54% | 81,720 | - |
| 440 | VERU | Veru Inc. | 36.92M | 1.32% | 24,529 | 16.89M |
| 441 | NBY | NovaBay Pharmaceuticals, Inc. | 36.74M | 18.97% | 1,065,902 | 10.30M |
| 442 | PTN | Palatin Technologies, Inc. | 36.29M | -4.01% | 7,339 | 8.96M |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 35.56M | 2.70% | 310,968 | 90.00K |
| 444 | CELU | Celularity Inc. | 34.89M | -0.82% | 33,761 | 40.58M |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 33.77M | 2.27% | 43,620 | - |
| 446 | SER | Serina Therapeutics, Inc. | 33.59M | 24.02% | 10,988,253 | 116.00K |
| 447 | JSPR | Jasper Therapeutics, Inc. | 33.30M | -3.25% | 256,605 | - |
| 448 | INMB | INmune Bio Inc. | 32.97M | 5.98% | 549,054 | 50.00K |
| 449 | TLSA | Tiziana Life Sciences Ltd | 32.08M | 11.57% | 385,493 | - |
| 450 | ABVC | ABVC BioPharma, Inc. | 31.29M | 0.82% | 53,208 | 797.92K |
| 451 | RNTX | Rein Therapeutics Inc. | 31.28M | -4.03% | 38,141 | - |
| 452 | DYAI | Dyadic International, Inc. | 31.12M | -8.51% | 96,264 | 3.34M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 30.95M | 1.67% | 173,983 | - |
| 454 | PLUR | Pluri Inc. | 30.76M | -1.61% | 22,578 | 1.34M |
| 455 | CVM | CEL-SCI Corporation | 29.43M | 1.16% | 39,905 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 28.57M | -0.98% | 32,462 | 6.44M |
| 457 | XCUR | Exicure, Inc. | 27.98M | -1.35% | 32,895 | 500.00K |
| 458 | PDSB | PDS Biotechnology Corporation | 27.94M | -0.09% | 280,197 | - |
| 459 | HYPD | Hyperion DeFi, Inc. | 27.61M | 4.28% | 210,701 | 345.32K |
| 460 | OTLK | Outlook Therapeutics, Inc. | 26.56M | -8.91% | 2,282,611 | 205.70K |
| 461 | ENLV | Enlivex Ltd. | 26.48M | 8.82% | 277,230 | - |
| 462 | CUE | Cue Biopharma, Inc. | 26.00M | 0.15% | 1,421,771 | 27.47M |
| 463 | BOLD | Boundless Bio, Inc. | 25.77M | -3.36% | 72,479 | - |
| 464 | IGC | IGC Pharma, Inc. | 25.57M | -3.81% | 221,617 | 1.11M |
| 465 | LTRN | Lantern Pharma Inc. | 25.05M | 5.16% | 23,346 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 24.92M | -3.17% | 2,034 | 14.97M |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 24.85M | - | 59,548 | 14.99M |
| 468 | TPST | Tempest Therapeutics, Inc. | 24.81M | -19.65% | 449,292 | - |
| 469 | NRSN | NeuroSense Therapeutics Ltd. | 24.75M | -1.59% | 131,131 | - |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 24.42M | 1.22% | 247,039 | 789.00K |
| 471 | SNTI | Senti Biosciences, Inc. | 23.66M | -2.17% | 40,823 | - |
| 472 | PASG | Passage Bio, Inc. | 22.58M | -5.25% | 51,243 | - |
| 473 | LGVN | Longeveron Inc. | 22.18M | -2.71% | 620,829 | 1.20M |
| 474 | MRKR | Marker Therapeutics, Inc. | 21.84M | -2.24% | 129,008 | 3.55M |
| 475 | SKYE | Skye Bioscience, Inc. | 21.42M | -1.11% | 163,749 | - |
| 476 | NNVC | NanoViricides, Inc. | 21.17M | -4.83% | 175,705 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 20.31M | -2.46% | 88,322 | 570.00K |
| 478 | DARE | Daré Bioscience, Inc. | 19.58M | 0.74% | 76,684 | -57.13K |
| 479 | LEXX | Lexaria Bioscience Corp. | 18.17M | 2.34% | 38,632 | 522.00K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 18.03M | 5.56% | 103,357 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 17.78M | -3.39% | 35,845 | - |
| 482 | TRAW | Traws Pharma, Inc. | 17.74M | 3.74% | 42,906 | 2.85M |
| 483 | FBLG | FibroBiologics, Inc. | 16.89M | -1.61% | 607,210 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 16.81M | -2.52% | 468,290 | 3.94M |
| 485 | INAB | IN8bio, Inc. | 16.35M | -17.00% | 239,685 | - |
| 486 | INTS | Intensity Therapeutics, Inc. | 15.76M | 4.01% | 18,768 | - |
| 487 | AEON | AEON Biopharma, Inc. | 15.46M | 4.67% | 33,912 | - |
| 488 | LIXT | Lixte Biotechnology Holdings, Inc. | 15.17M | -2.92% | 13,327 | - |
| 489 | IOBT | IO Biotech, Inc. | 15.04M | 18.35% | 1,808,018 | - |
| 490 | COCP | Cocrystal Pharma, Inc. | 14.89M | 4.85% | 37,889 | - |
| 491 | GTBP | GT Biopharma, Inc. | 14.78M | 1.83% | 746,633 | - |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 14.52M | 2.46% | 662,729 | - |
| 493 | HOTH | Hoth Therapeutics, Inc. | 14.48M | 2.03% | 139,287 | - |
| 494 | PLRZ | Polyrizon Ltd. | 14.02M | 4.38% | 19,231 | - |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 13.73M | -3.90% | 173,625 | - |
| 496 | CLRB | Cellectar Biosciences, Inc. | 13.23M | -3.70% | 22,982 | - |
| 497 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.19M | 2.77% | 5,828 | - |
| 498 | ACXP | Acurx Pharmaceuticals, Inc. | 12.92M | -19.20% | 725,790 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 12.89M | 3.25% | 215,204 | - |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 12.77M | -5.67% | 73,783 | - |
| 501 | GNTA | Genenta Science S.p.A. | 12.74M | 5.53% | 103,949 | - |
| 502 | BCDA | BioCardia, Inc. | 12.74M | - | 49,015 | 3.00K |
| 503 | QNTM | Quantum BioPharma Ltd. | 12.35M | 38.39% | 1,408,568 | - |
| 504 | OSRH | OSR Holdings, Inc. | 12.29M | 9.59% | 9,176,096 | -90.52K |
| 505 | SNGX | Soligenix, Inc. | 12.20M | 0.83% | 60,489 | 2.34K |
| 506 | CMMB | Chemomab Therapeutics Ltd. | 12.08M | -5.62% | 85,148 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 11.89M | -6.36% | 20,174 | 573.19K |
| 508 | MBRX | Moleculin Biotech, Inc. | 11.21M | 1.94% | 70,865 | - |
| 509 | NCEL | NewcelX Ltd. | 11.17M | 3.38% | 8,694 | - |
| 510 | CALC | CalciMedica, Inc. | 10.18M | 11.95% | 328,790 | - |
| 511 | BLRX | BioLineRx Ltd. | 10.10M | -12.45% | 71,480 | 1.18M |
| 512 | BIVI | BioVie Inc. | 10.03M | 10.83% | 70,808 | - |
| 513 | BCAB | BioAtla, Inc. | 9.99M | 0.83% | 813,880 | 11.00M |
| 514 | LNAI | Lunai Bioworks Inc. | 9.93M | -12.38% | 4,214,122 | - |
| 515 | TOVX | Theriva Biologics, Inc. | 9.64M | 8.42% | 258,457,324 | - |
| 516 | CRIS | Curis, Inc. | 9.56M | -4.07% | 180,249 | 9.44M |
| 517 | IMNN | Imunon, Inc. | 9.15M | 3.83% | 32,954 | - |
| 518 | ITRM | Iterum Therapeutics plc | 8.98M | 5.46% | 378,625 | 390.00K |
| 519 | BOLT | Bolt Biotherapeutics, Inc. | 8.42M | -7.98% | 18,268 | 7.70M |
| 520 | PULM | Pulmatrix, Inc. | 8.25M | -9.24% | 24,905 | 3.00K |
| 521 | RNAZ | TransCode Therapeutics, Inc. | 8.24M | 0.11% | 6,201 | - |
| 522 | EVGN | Evogene Ltd. | 8.15M | 10.48% | 579,626 | 3.85M |
| 523 | ICU | SeaStar Medical Holding Corporation | 7.97M | -0.90% | 53,749 | 881.00K |
| 524 | APRE | Aprea Therapeutics, Inc. | 7.81M | -10.50% | 76,946 | 285.76K |
| 525 | PMCB | PharmaCyte Biotech, Inc. | 7.76M | 5.23% | 190,581 | - |
| 526 | CLGN | CollPlant Biotechnologies Ltd. | 7.76M | -1.30% | 16,611 | 2.48M |
| 527 | APM | Aptorum Group Limited | 7.68M | 12.04% | 534,389 | - |
| 528 | ADXN | Addex Therapeutics Ltd | 7.59M | 9.89% | 6,822 | 198.82K |
| 529 | KPRX | Kiora Pharmaceuticals, Inc. | 7.50M | -2.39% | 46,929 | 20.00K |
| 530 | PHGE | BiomX Inc. | 7.39M | -5.11% | 27,690 | - |
| 531 | SPRC | SciSparc Ltd. | 7.33M | -2.38% | 8,013 | 1.31M |
| 532 | XBIO | Xenetic Biosciences, Inc. | 7.17M | -3.99% | 11,666 | 2.98M |
| 533 | TCRT | Alaunos Therapeutics, Inc. | 7.14M | -0.62% | 3,202 | 6.00K |
| 534 | GRDX | GridAI Technologies Corp. | 7.09M | 2.93% | 83,277 | - |
| 535 | ALZN | Alzamend Neuro, Inc. | 7.08M | 1.64% | 36,743 | - |
| 536 | NCNA | NuCana plc | 6.91M | 0.61% | 37,435 | - |
| 537 | CELZ | Creative Medical Technology Holdings, Inc. | 6.88M | 1.09% | 27,459 | 6.00K |
| 538 | ERNA | Ernexa Therapeutics Inc. | 6.85M | -11.55% | 2,992,211 | 1,000.00 |
| 539 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.66M | -1.75% | 171,425 | 14.83K |
| 540 | PCSA | Processa Pharmaceuticals, Inc. | 6.25M | 1.29% | 6,666 | - |
| 541 | CYCN | Cyclerion Therapeutics, Inc. | 6.24M | - | 31,014 | 2.86M |
| 542 | LIMN | Liminatus Pharma, Inc. | 5.73M | -0.09% | 804,216 | - |
| 543 | IMRN | Immuron Limited | 5.72M | -0.43% | 10,729 | 4.99M |
| 544 | QNCX | Quince Therapeutics, Inc. | 5.66M | 27.00% | 17,963,747 | - |
| 545 | ARTL | Artelo Biosciences, Inc. | 5.64M | -3.89% | 497,286 | - |
| 546 | PBM | Psyence Biomedical Ltd. | 5.57M | 1.25% | 15,535 | - |
| 547 | MBIO | Mustang Bio, Inc. | 5.47M | -4.14% | 31,118 | - |
| 548 | MLEC | Moolec Science SA | 5.37M | -9.88% | 10,892 | 7.83M |
| 549 | AKTX | Akari Therapeutics, Plc | 5.18M | 11.45% | 351,672 | - |
| 550 | XTLB | XTL Biopharmaceuticals Ltd. | 5.14M | -1.24% | 22,221 | 968.00K |
| 551 | BGMS | Bio Green Med Solution, Inc. | 5.05M | 9.59% | 161,409 | 81.00K |
| 552 | AZTR | Azitra, Inc. | 4.81M | 5.09% | 25,207,430 | 7.50K |
| 553 | SILO | Silo Pharma, Inc. | 4.63M | -3.42% | 158,066 | 72.10K |
| 554 | REVB | Revelation Biosciences, Inc. | 4.54M | 2.52% | 35,337 | - |
| 555 | GNPX | Genprex, Inc. | 4.43M | 1.60% | 213,696 | - |
| 556 | ASBP | Aspire Biopharma Holdings, Inc. | 4.37M | 21.07% | 348,840 | 1.94K |
| 557 | VIVS | VivoSim Labs, Inc. | 4.33M | -1.19% | 80,503 | 142.00K |
| 558 | BDRX | Biodexa Pharmaceuticals Plc | 4.24M | -2.37% | 90,937 | 104.90K |
| 559 | SLXN | Silexion Therapeutics Corp | 4.23M | 4.10% | 25,141 | - |
| 560 | APVO | Aptevo Therapeutics Inc. | 4.20M | -1.54% | 31,747 | - |
| 561 | MTNB | Matinas BioPharma Holdings, Inc. | 4.10M | - | 54,359 | - |
| 562 | INDP | Indaptus Therapeutics, Inc. | 3.88M | 1.76% | 11,504 | - |
| 563 | GRI | GRI Bio, Inc. | 3.74M | 9.75% | 44,856 | - |
| 564 | PPBT | Purple Biotech Ltd | 3.70M | - | 7,710 | - |
| 565 | XRTX | XORTX Therapeutics Inc. | 3.25M | 2.53% | 31,927 | - |
| 566 | GLMD | Galmed Pharmaceuticals Ltd. | 3.18M | -3.25% | 111,110 | - |
| 567 | OGEN | Oragenics, Inc. | 2.95M | -8.93% | 170,825 | - |
| 568 | BRTX | BioRestorative Therapies, Inc. | 2.90M | 16.79% | 4,596,447 | 383.40K |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.78M | -1.96% | 12,402 | - |
| 570 | ADIL | Adial Pharmaceuticals, Inc. | 2.63M | -8.00% | 48,024 | - |
| 571 | ONCO | Onconetix, Inc. | 2.16M | -2.95% | 190,214 | 815.37K |
| 572 | SCNI | Scinai Immunotherapeutics Ltd. | 2.14M | -3.89% | 24,169 | 1.15M |
| 573 | BBLG | Bone Biologics Corporation | 2.12M | 1.72% | 6,112 | - |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.11M | 4.24% | 345,588 | - |
| 575 | ENSC | Ensysce Biosciences, Inc. | 2.07M | 0.19% | 433,749 | 4.49M |
| 576 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.94M | -6.15% | 174,017 | 1.36M |
| 577 | KALA | KALA BIO, Inc. | 1.91M | -1.73% | 2,914,850 | - |
| 578 | DRMA | Dermata Therapeutics, Inc. | 1.85M | 7.53% | 2,426,212 | - |
| 579 | PPCB | Propanc Biopharma, Inc. | 1.78M | -0.76% | 3,775,355 | - |
| 580 | HCWB | HCW Biologics Inc. | 1.70M | -29.90% | 2,739,481 | 422.03K |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 1.56M | 9.83% | 24,210 | - |
| 582 | JAGX | Jaguar Health, Inc. | 1.49M | -4.82% | 340,840 | 11.79M |
| 583 | CMND | Clearmind Medicine Inc. | 1.01M | 1.74% | 102,532 | - |
| 584 | OKYO | OKYO Pharma Limited | 949.93K | 5.10% | 50,947 | - |
| 585 | CDT | CDT Equity Inc. | 791.89K | -0.14% | 50,162 | - |
| 586 | VRAX | Virax Biolabs Group Limited | 766.36K | 1.91% | 101,595 | 2.99K |
| 587 | ADTX | Aditxt, Inc. | 604.20K | -16.92% | 206,506 | 5.95K |
| 588 | ELAB | PMGC Holdings Inc. | 313.14K | 5.97% | 23,299 | 285.95K |
| 589 | MTVA | MetaVia Inc. | 305.27K | 3.55% | 362,262 | - |
| 590 | CANF | Can-Fite BioPharma Ltd. | 18.44K | 2.21% | 29,424 | 560.00K |